MedRx Co., Ltd (TYO:4586)
Japan · Delayed Price · Currency is JPY 67.00
+1.00 (1.52%)
Aug 27, 2026, 3:30 PM JST
MedRx Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -846 | -925 | -802 | -930 | -1,109 | -1,058 |
Depreciation & Amortization | 8 | 13 | 38 | 45 | 46 | 60 |
Loss (Gain) From Sale of Investments | - | - | 68 | - | - | - |
Other Operating Activities | 3 | - | 49 | - | - | 8 |
Change in Inventory | -21 | -6 | - | -1 | 3 | 8 |
Change in Accounts Payable | 13 | -37 | - | -58 | 32 | 52 |
Change in Other Net Operating Assets | -52 | 67 | -156 | 31 | -45 | 7 |
Operating Cash Flow | -895 | -888 | -803 | -913 | -1,073 | -923 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -85 | -82 | - | - | -1 | -2 |
Other Investing Activities | - | - | -3 | - | - | - |
Investing Cash Flow | -85 | -82 | -3 | - | -1 | -2 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | - | - | - | 550 |
Total Debt Issued | - | - | - | - | - | 550 |
Short-Term Debt Repaid | - | - | - | - | - | -50 |
Long-Term Debt Repaid | - | - | - | - | - | -550 |
Total Debt Repaid | - | - | - | - | - | -600 |
Net Debt Issued (Repaid) | - | - | - | - | - | -50 |
Issuance of Common Stock | 450 | 745 | 1,066 | 1,639 | 356 | 865 |
Financing Cash Flow | 450 | 745 | 1,066 | 1,639 | 356 | 815 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 7 | 2 | -3 | 1 | 9 | 1 |
Miscellaneous Cash Flow Adjustments | -1 | 1 | -1 | -1 | - | 1 |
Net Cash Flow | -524 | -222 | 256 | 726 | -709 | -108 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -980 | -970 | -803 | -913 | -1,074 | -925 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -809.92% | -757.81% | -312.45% | -3148.28% | -1820.34% | -11562.50% |
Free Cash Flow Per Share | -16.63 | -18.05 | -18.47 | -26.25 | -42.34 | -43.31 |
Levered Free Cash Flow | -706.5 | -660.75 | -481.63 | -569.75 | -652.13 | -529.75 |
Unlevered Free Cash Flow | -706.5 | -660.75 | -481.63 | -569.75 | -652.13 | -529.13 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | - | - | - | - | - | 1 |
Cash Income Tax Paid | - | 3 | 4 | 2 | 2 | 1 |
Change in Working Capital | -60 | 24 | -156 | -28 | -10 | 67 |